Physician profile
Derron Wilson
NPI 1780669267
$616,232.33
in general payments reported to CMS, 2019-2025
14 companies · $131K in 2025
The $131K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $45K · 2021: $103K · 2022: $76K · 2023: $57K · 2024: $111K · 2025: $131K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $107K · Travel and Lodging: $65K · Consulting Fee: $56K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $55K · Food and Beverage: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $107,282.26 |
| Travel and Lodging | $65,413.59 |
| Consulting Fee | $55,746.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $55,412.50 |
| Food and Beverage | $15,439.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $492,028.23 | 2019-2025 | Proclaim, Eterna, Prodigy |
| Boston Scientific Corporation | $75,815.29 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Saluda Medical Americas, INC. | $37,428.67 | 2024-2025 | Evoke |
| Biotronik INC. | $8,683.06 | 2021-2025 | |
| Biotronik Nro, INC. | $681.05 | 2023-2025 | Prospera, Biotronik |
| Medtronic, INC. | $507.54 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $364.94 | 2019-2023 | Senza |
| Curonix LLC | $227.42 | 2022-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $216.45 | 2025 | Senza |
| Spr Therapeutics, INC | $118.48 | 2022-2024 | Sprint Pns System |
| Stimwave Technologies Incorporated | $116.99 | 2022 | |
| Relievant Medsystems, INC. | $15.98 | 2021 | |
| Ucb, INC. | $15.21 | 2019 | |
| Medline Industries Lp | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derron Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.